Clinical Trial Update: Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine in Frequent Platelets Donors [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing immunogenicity of a quadrivalent meningococcal conjugate vaccine in frequent platelet donors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis

Drugs mentioned

• Quadrivalent meningococcal conjugate vaccine (meningococcal conjugate vaccine quadrivalent (MenACWY))

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Preventive Immunization; Meningitis | Phase 4 | Status: UNKNOWN